WeVote

Bill

Bill

SB 2208

RELATING TO PHARMACY BENEFIT MANAGERS.

2026 Regular Session Introduced by Stanley Chang and 3 co-sponsors

Hawaii SB 2208 introduces regulatory oversight of Pharmacy Benefit Managers to increase transparency and consumer protections in prescription drug benefits management.

Referred to HHS/CPN, WAM/JDC.
0
WeVote Research Nonpartisan
Bill Summary · SB 2208

Legislative bill overview

SB 2208 addresses regulations governing Pharmacy Benefit Managers (PBMs) in Hawaii. The bill appears designed to increase oversight and transparency requirements for PBMs, which are intermediaries that manage prescription drug benefits for health insurance plans. While the specific provisions aren't detailed in the available information, the referral to health and consumer protection committees suggests it may involve consumer protections, pricing transparency, or operational standards.

Why is this important

PBMs significantly influence drug pricing, patient access, and pharmacy operations across the state. Regulatory changes to PBM practices directly affect prescription drug costs for consumers, insurance premiums, and the viability of independent pharmacies. Hawaii residents and healthcare providers have experienced rising concerns about PBM practices nationally, making state-level regulation potentially impactful for the local healthcare market.

Potential points of contention

  • Industry pushback: PBMs may argue that increased regulation raises administrative costs and could reduce competition or innovation in prescription drug management
  • Scope definition: Disagreement over how broadly regulations apply (e.g., which PBM activities are covered, what transparency requirements are mandatory)
  • Implementation feasibility: Questions about whether Hawaii can enforce regulations on PBMs operating across multiple states and whether federal law preempts certain state requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.